Literature DB >> 16308204

A novel sulphur glycoside from the seeds of Descurainia sophia (L.).

K Sun1, X Li, J-M Liu, J-H Wang, W Li, Y Sha.   

Abstract

A new sulphur glycoside, named descurainoside (1), and the known compound sinapic acid (2) have been isolated from the seeds of Descurainia sophia (L.) Webb ex Prantl. The structure of 1 has been identified as (1R,6S,8R,9S,10S)-9,10-dihydroxy-4-[(4-hydroxy-3,5-dimethoxyphenyl)methylene]-8-(hydroxymethyl)-2,7-dioxa-5-thiabicyclo[4.4.0]decan-3-one by means of physico-chemical properties and spectroscopic methods (1D and 2D NMR, HRMS, ESI-MS).

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16308204     DOI： 10.1080/1028602042000204072

Source DB:  PubMed          Journal:  J Asian Nat Prod Res        ISSN： 1028-6020            Impact factor:   1.569


  14 in total

Review 1.  Traditional, complementary and alternative medicine in children constipation: a systematic review.

Authors:  Maryam Sadat Paknejad; Monireh Sadat Motaharifard; Shahdis Barimani; Payam Kabiri; Mehrdad Karimi
Journal:  Daru       Date:  2019-11-16       Impact factor: 3.117

2.  Optimization of supercritical fluid extraction of essential oils and fatty acids from flixweed (Descurainia Sophia L.) seed using response surface methodology and central composite design.

Authors:  Katayoun Mahdavi Ara; Mina Jowkarderis; Farhad Raofie
Journal:  J Food Sci Technol       Date:  2015-03-07       Impact factor: 2.701

3.  Evaluation of genetic diversity amongst Descurainia sophia L. genotypes by inter-simple sequence repeat (ISSR) marker.

Authors:  Sahar Saki; Hedayat Bagheri; Ali Deljou; Mehrshad Zeinalabedini
Journal:  Physiol Mol Biol Plants       Date:  2015-11-14

4.  Cytotoxic evaluation of volatile oil from Descurainia sophia seeds on MCF-7 and HeLa cell lines.

Authors:  E Khodarahmi; G H Asghari; F Hassanzadeh; M Mirian; G A Khodarahmi
Journal:  Res Pharm Sci       Date:  2015 Mar-Apr

5.  Flixweed vs. Polyethylene Glycol in the Treatment of Childhood Functional Constipation: A Randomized Clinical Trial.

Authors:  Majid Nimrouzi; Omid Sadeghpour; Mohammad Hadi Imanieh; Mohammadreza Shams Ardekani; Alireza Salehi; Mohamad Bagher Minaei; Mohammad M Zarshenas
Journal:  Iran J Pediatr       Date:  2015-04-18       Impact factor: 0.364

6.  Effect of an ethanol extract of Descurainia sophia seeds on Phase I and II drug metabolizing enzymes and P-glycoprotein activity in vitro.

Authors:  Jin-Mu Yi; Young Ah Kim; You Jin Lee; Ok-Sun Bang; No Soo Kim
Journal:  BMC Complement Altern Med       Date:  2015-12-18       Impact factor: 3.659

7.  Helveticoside is a biologically active component of the seed extract of Descurainia sophia and induces reciprocal gene regulation in A549 human lung cancer cells.

Authors:  Bu-Yeo Kim; Jun Lee; No Soo Kim
Journal:  BMC Genomics       Date:  2015-09-18       Impact factor: 3.969

8.  Gene Expression Profile of the A549 Human Non-Small Cell Lung Carcinoma Cell Line following Treatment with the Seeds of Descurainia sophia, a Potential Anticancer Drug.

Authors:  Bu-Yeo Kim; Jun Lee; Sung Joon Park; Ok-Sun Bang; No Soo Kim
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-27       Impact factor: 2.629

9.  Ethanolic extract of Descurainia sophia seeds sensitizes A549 human lung cancer cells to TRAIL cytotoxicity by upregulating death receptors.

Authors:  Jong-Shik Park; Chae Jun Lim; Ok-Sun Bang; No Soo Kim
Journal:  BMC Complement Altern Med       Date:  2016-04-02       Impact factor: 3.659

Review 10.  Phytochemical and pharmacological aspects of Descurainia sophia Webb ex Prantl: modern and traditional applications.

Authors:  Majid Nimrouzi; Mohammad Mahdi Zarshenas
Journal:  Avicenna J Phytomed       Date:  2016 May-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.